Published in Acta Psychiatr Scand Suppl on January 01, 1989
Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med (2008) 11.44
Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. BMJ (2003) 7.78
Systematic Review and Meta-Analysis: Dose-Response Relationship of Selective Serotonin Reuptake Inhibitors in Major Depressive Disorder. Am J Psychiatry (2015) 1.55
Comparative efficacy of antidepressants. Drugs (1992) 1.25
Paroxetine combined with a 5-HT(1A) receptor antagonist reversed reward deficits observed during amphetamine withdrawal in rats. Psychopharmacology (Berl) (2004) 0.87
The efficacy of paroxetine and placebo in treating anxiety and depression: a meta-analysis of change on the Hamilton Rating Scales. PLoS One (2014) 0.83
Latency to paroxetine-induced anxiolysis in the rat is reduced by co-administration of the 5-HT(1A) receptor antagonist WAY100635. Br J Pharmacol (2000) 0.81
Effects of acute paroxetine administration on tryptophan metabolism and disposition in the rat. Br J Pharmacol (1991) 0.76
A novel complex of nucleoporins, which includes Sec13p and a Sec13p homolog, is essential for normal nuclear pores. Cell (1996) 4.37
The redundancy of ribosomal and transfer RNA genes in Saccharomyces cerevisiae. J Mol Biol (1969) 3.54
Detection of serum antibodies to Borna disease virus in patients with psychiatric disorders. Science (1985) 2.57
The antibody crossmatch in liver transplantation. Surgery (1986) 2.33
The multifunctional 6-methylsalicylic acid synthase gene of Penicillium patulum. Its gene structure relative to that of other polyketide synthases. Eur J Biochem (1990) 2.17
[Rational hormone diagnosis in normocyclic functional sterility]. Geburtshilfe Frauenheilkd (1991) 2.06
A Saccharomyces cerevisiae mutant defective in saturated fatty acid biosynthesis. Proc Natl Acad Sci U S A (1970) 2.02
A novel nuclear pore protein Nup82p which specifically binds to a fraction of Nsp1p. J Cell Biol (1995) 1.90
A new gene cluster in yeast: the fatty acid synthetase system. Hoppe Seylers Z Physiol Chem (1971) 1.82
Comparison of two dosage regimens of fluoxetine in major depression. J Clin Psychiatry (1985) 1.72
The pentafunctional FAS1 gene of yeast: its nucleotide sequence and order of the catalytic domains. Mol Gen Genet (1986) 1.60
On the regulation of ribosomal RNA synthesis in yeast. Exp Cell Res (1969) 1.57
Systematic analysis of yeast strains with possible defects in lipid metabolism. Yeast (1999) 1.52
Coordinate genetic control of yeast fatty acid synthase genes FAS1 and FAS2 by an upstream activation site common to genes involved in membrane lipid biosynthesis. EMBO J (1992) 1.47
Yeast transcriptional activator INO2 interacts as an Ino2p/Ino4p basic helix-loop-helix heteromeric complex with the inositol/choline-responsive element necessary for expression of phospholipid biosynthetic genes in Saccharomyces cerevisiae. Nucleic Acids Res (1995) 1.46
Moclobemide in social phobia: a controlled dose-response trial. J Clin Psychopharmacol (1997) 1.46
Mitochondrial acyl carrier protein is involved in lipoic acid synthesis in Saccharomyces cerevisiae. FEBS Lett (1997) 1.42
CREB-binding protein/p300 activates MyoD by acetylation. J Biol Chem (2000) 1.42
Interruption of selective serotonin reuptake inhibitor treatment. Double-blind, placebo-controlled trial. Br J Psychiatry (2000) 1.37
Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation. Arch Gen Psychiatry (1990) 1.35
Mapping of a complex gene locus coding for part of the Saccharomyces cerevisiae fatty acid synthetase multienzyme complex. Mol Gen Genet (1972) 1.34
A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation. Eur J Immunol (1995) 1.29
Hyaluronan and a cell-associated hyaluronan binding protein regulate the locomotion of ras-transformed cells. J Cell Biol (1991) 1.28
Identification of melanin concentrating hormone (MCH) as the natural ligand for the orphan somatostatin-like receptor 1 (SLC-1). FEBS Lett (1999) 1.27
The cellular control of fatty acid synthesis at the enzymatic level. Biochem Soc Symp (1963) 1.26
The replication of mitochondrial DNA during the cell cycle in Saccharomyces lactis. Proc Natl Acad Sci U S A (1968) 1.23
Is premenstrual dysphoric disorder a distinct clinical entity? J Womens Health Gend Based Med (1999) 1.21
Pantetheine-free mutants of the yeast fatty-acid-synthetase complex. Eur J Biochem (1973) 1.20
Regulation of glutamate dehydrogenase by reversible ADP-ribosylation in mitochondria. EMBO J (2001) 1.19
The efficacy and safety of paroxetine compared with placebo in outpatients with major depression. J Clin Psychiatry (1992) 1.19
Treatment resistant depression: methodological overview and operational criteria. Eur Neuropsychopharmacol (1999) 1.18
Synaptic scaffolding proteins in rat brain. Ankyrin repeats of the multidomain Shank protein family interact with the cytoskeletal protein alpha-fodrin. J Biol Chem (2001) 1.18
Characterization of recombinant human nicotinamide mononucleotide adenylyl transferase (NMNAT), a nuclear enzyme essential for NAD synthesis. FEBS Lett (2001) 1.17
Comprehensive laboratory evaluations of the molluscicide 2',5-dichloro-4'-nitro-3-phenylsalicylanilide (PSA): time-concentration relationships and susceptibilities of stage-size arrays of snails. Bull World Health Organ (1968) 1.14
Sertraline in the treatment of panic disorder. A multi-site, double-blind, placebo-controlled, fixed-dose investigation. Br J Psychiatry (1998) 1.14
Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam. Arch Gen Psychiatry (1993) 1.13
A novel function of yeast fatty acid synthase. Subunit alpha is capable of self-pantetheinylation. Eur J Biochem (2000) 1.11
Biochemical analysis of SopE from Salmonella typhimurium, a highly efficient guanosine nucleotide exchange factor for RhoGTPases. J Biol Chem (1999) 1.11
The effects of high-dose recombinant soluble CD4 on human immunodeficiency virus type 1 viremia. J Infect Dis (1994) 1.10
Purification and characterization of N-acetylglucosamine kinase from rat liver--comparison with UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase. Eur J Biochem (1998) 1.09
Nefazodone and imipramine in major depression: a placebo-controlled trial. Br J Psychiatry (1994) 1.08
Use of pattern analysis to predict differential relapse of remitted patients with major depression during 1 year of treatment with fluoxetine or placebo. Arch Gen Psychiatry (1998) 1.07
The inotropic effects of digoxin in hyperkalemia. Relation to (Na+,K+)-ATPase inhibition in the intact animal. Circulation (1973) 1.07
Suppressor factor from a T cell hybrid inhibits delayed-type hypersensitivity responses to azobenzenearsonate. Proc Natl Acad Sci U S A (1981) 1.06
Effects of Bayluscide against Australorbis glabratus of different ages, strains and cultural conditions. Bull World Health Organ (1966) 1.05
Differential proteolytic sensitivity of yeast fatty acid synthetase subunits alpha and beta contributing to a balanced ratio of both fatty acid synthetase components. Eur J Biochem (1992) 1.04
Fatty-acid elongation in a mutant of Saccharomyces cerevisiae deficient in fatty-acid synthetase. Eur J Biochem (1972) 1.04
DNA binding site of the yeast heteromeric Ino2p/Ino4p basic helix-loop-helix transcription factor: structural requirements as defined by saturation mutagenesis. FEBS Lett (1995) 1.03
The clinical course and long-term management of generalized anxiety disorder. J Clin Psychopharmacol (1990) 1.03
Neuroanatomical substrates of late-life minor depression. A quantitative magnetic resonance imaging study. Arch Neurol (1997) 1.03
The pentafunctional FAS1 genes of Saccharomyces cerevisiae and Yarrowia lipolytica are co-linear and considerably longer than previously estimated. Mol Gen Genet (1991) 1.02
Regulatory gene INO4 of yeast phospholipid biosynthesis is positively autoregulated and functions as a transactivator of fatty acid synthase genes FAS1 and FAS2 from Saccharomyces cerevisiae. Nucleic Acids Res (1992) 1.01
Fatty acid-requiring mutant of Saccharomyces cerevisiae defective in acetyl-CoA carboxylase. Proc Natl Acad Sci U S A (1980) 1.01
Gemcitabine-docetaxel versus cisplatin-vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin. Ann Oncol (2005) 1.01
Identification of the plasma membrane H+-biotin symporter of Saccharomyces cerevisiae by rescue of a fatty acid-auxotrophic mutant. J Biol Chem (1999) 1.00
Efficacy and safety of fluoxetine in treating bipolar II major depressive episode. J Clin Psychopharmacol (1998) 1.00
Purification and characterization of an inducible metalloprotease inhibitor from the hemolymph of greater wax moth larvae, Galleria mellonella. Eur J Biochem (1998) 0.99
Fatty acid biosynthesis in yeast. Mol Cell Biochem (1978) 0.99
Expression of a functional fungal polyketide synthase in the bacterium Streptomyces coelicolor A3(2). J Bacteriol (1995) 0.99
rDNA replication in a synchronized culture of Saccharomyces cerevisiae. Biochem Biophys Res Commun (1972) 0.98
Glycoprotein topology on intact human red blood cells reevaluated by cross-linking following amino group supplementation. Biochemistry (1982) 0.98
Yeast mutants defective in acetyl-coenzyme A carboxylase and biotin: apocarboxylase ligase. Eur J Biochem (1980) 0.98
Fatty acid elongation in yeast--biochemical characteristics of the enzyme system and isolation of elongation-defective mutants. Eur J Biochem (1998) 0.98
The clinical application of tricyclic antidepressant pharmacokinetics and plasma levels. Am J Psychiatry (1980) 0.96
Long-term benzodiazepine users 3 years after participation in a discontinuation program. Am J Psychiatry (1991) 0.96
What constitutes an adequate antidepressant trial for fluoxetine? J Clin Psychiatry (1990) 0.95
Genetic analysis of non-complementing fatty acid synthetase mutants in Saccharomyces cerevisiae. Mol Gen Genet (1974) 0.94
Properties of two nuclear pet mutants affecting expression of the mitochondrial oli1 gene of Saccharomyces cerevisiae. Curr Genet (1991) 0.94
Molecular cloning of the yeast fatty acid synthetase genes, FAS1 and FAS2: illustrating the structure of the FAS1 cluster gene by transcript mapping and transformation studies. Mol Gen Genet (1984) 0.94
Highly sensitive gas chromatographic-tandem mass spectrometric method for the determination of morphine and codeine in serum and urine in the femtomolar range. J Chromatogr B Biomed Sci Appl (1999) 0.93
Antibacterial activities of nitrothiazole derivatives. J Antimicrob Chemother (1984) 0.93
Placebo-controlled trial of venlafaxine for the treatment of major depression. J Clin Psychopharmacol (1991) 0.93
The prophenoloxidase from the wax moth Galleria mellonella: purification and characterization of the proenzyme. Insect Biochem Mol Biol (1995) 0.93
Dose escalation of cyclophosphamide in patients with breast cancer: consequences for pharmacokinetics and metabolism. J Clin Oncol (1997) 0.92
Anticoagulant effects of hirulog, a novel thrombin inhibitor, in patients with coronary artery disease. Am J Cardiol (1993) 0.92
Structure and metabolic control of the Yarrowia lipolytica peroxisomal 3-oxoacyl-CoA-thiolase gene. Eur J Biochem (1993) 0.92
Differences in nocturnal melatonin secretion between melancholic depressed patients and control subjects. Am J Psychiatry (1985) 0.91
Purification and characterization of the lysozyme from the gut of the soft tick Ornithodoros moubata. Insect Biochem Mol Biol (1999) 0.91
The clinical presentation of generalized anxiety in primary-care settings: practical concepts of classification and management. J Clin Psychiatry (1997) 0.91
Seroprevalence and disease association of antineutrophil cytoplasmic autoantibodies and antigens in HIV infection. Infection (1999) 0.91
Importance of general regulatory factors Rap1p, Abf1p and Reb1p for the activation of yeast fatty acid synthase genes FAS1 and FAS2. Eur J Biochem (1994) 0.91
The Brucella suis homologue of the Agrobacterium tumefaciens chromosomal virulence operon chvE is essential for sugar utilization but not for survival in macrophages. J Bacteriol (2001) 0.91
Isolation and sequence analysis of the fatty acid synthetase FAS2 gene from Penicillium patulum. Eur J Biochem (1988) 0.91
Insect immune activation by recombinant Galleria mellonella apolipophorin III(1). Biochim Biophys Acta (1999) 0.90
Long-term treatment of anxiety and risk of withdrawal. Prospective comparison of clorazepate and buspirone. Arch Gen Psychiatry (1988) 0.90
Benzodiazepine dependence: management of discontinuation. Psychopharmacol Bull (1990) 0.90
Pharmacokinetics and the pharmacodynamic action of midazolam in young and elderly patients undergoing tooth extraction. Clin Pharmacol Ther (1998) 0.89
Pleiotropic phenotype of acetyl-CoA-carboxylase-defective yeast cells--viability of a BPL1-amber mutation depending on its readthrough by normal tRNA(Gln)(CAG). Eur J Biochem (1998) 0.89